Department of Medicine

You are here

Hospital Epidemiology and Infection Control

Healthcare-Associated Infections

Calfee, Simon

The Hospital Epidemiology Program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has research activities ranging from traditional epidemiologic studies of infection control risk factors and outcomes, to intervention trials of infection control policies and procedures. The primary goal of the research program is to improve patient safety by reducing the risk of healthcare-associated infections. Observational studies can be carried out utilizing infection control surveillance data, clinical microbiology data, and a robust hospital-based clinical database, which can be queried electronically. Previous and ongoing projects have studied patient-oriented and systems-based factors associated with transmission of multidrug-resistant organisms, device-related infections, and procedure-related infections. In addition, the program has the potential for performing individual and cluster randomized trials of infection control interventions at Weill Cornell Medicine and in collaboration with Columbia University Medical Center. Funding for the research program currently includes a five-year grant from the New York State Department of Health. Fellows, residents and students interested in epidemiologic research can choose from a wide variety of large or small projects depending on their needs.

  • Banach DB, Francois J, Blash S, Patel G, Jenkins SG, LaBombardi V, Kreiswirth BN, Srinivasan A, Calfee DP. Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile. Infect Control Hosp Epidemiol 2014; 35:82-4.
  • Calfee DP, Salgado CD, Milstone AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:772-96.
  • Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich EN, Hall KK, Morgan DJ; and the Benefits of Universal Glove and Gown (BUGG) Investigators, Shahryar SK, Price CS, Gadbaw JJ, Drees M, Kett DH, Muñoz-Price LS, Jacob JT, Herwaldt LA, Sulis CA, Yokoe DS, Maragakis L, Lissauer ME, Zervos MJ, Warren DK, Carver RL, Anderson DJ, Calfee DP, Bowling JE, Safdar N. Universal glove and gown use and acquisition of antibiotic resistant bacteria in the ICU: a randomized trial. JAMA 2013; 310:1571-80.
  • Simon MS, Leff JA, Pandya A, Cushing M, Shaz BH, Calfee DP, Schackman BR, Mushlin AI. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion 2014; 54:889-99.
  • Swaminathan M, Sharma S, Blash S, Patel G, Banach DB, Phillips M, LaBombardi V, Anderson K, Kitchel B, Srinivasan A, Calfee DP. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol. 2013; 34:809-17.

Contact Information

Infectious Diseases

Roy M. Gulick, M.D., Chief

Avi Bueno, Administrator
Tel: (212) 746-4914
Fax: (212) 746-8675
aeb3001@med.cornell.edu

Patient Appointments & Inquiries

Infectious Diseases Associates & Weill Cornell Travel Medicine
1305 York Avenue, Floor 4
New York, NY 10021
Tel: (646) 962-TRIP (8747)

Division Events

Division News

Clinical Trials

Related Internal Links

PDF icon Division Brochure
PDF icon Travel Clinic Brochure

Related External Links

Center for Special Studies
Clinical & Translational Science Center
Cornell Clinical Trials Unit
Weill Cornell Global Health

Patient Care Links

Weill Cornell Travel Medicine
Infectious Diseases Associates